<DOC>
	<DOCNO>NCT00175890</DOCNO>
	<brief_summary>To evaluate safety efficacy levetiracetam use adjunctive treatment pediatric subject age 1 month less 4 year partial onset seizure . Subjects evaluate 48 hour inpatient video electroencephalogram ( selection evaluation ) . Other neuropsychological clinical assessment perform 34 day length study .</brief_summary>
	<brief_title>A Placebo-controlled Study Levetiracetam In Children ( 1mo 4yrs Age ) With Partial Onset Seizures .</brief_title>
	<detailed_description />
	<mesh_term>Seizures</mesh_term>
	<mesh_term>Epilepsies , Partial</mesh_term>
	<mesh_term>Pharmaceutical Solutions</mesh_term>
	<mesh_term>Etiracetam</mesh_term>
	<mesh_term>Piracetam</mesh_term>
	<criteria>Pediatric patient 1 month less 4 year age Pediatric patient diagnose refractory partial onset seizure , stable regimen one two antiepileptic drug least 2 partial onset seizure per week two week prior screen Patients must two partial onset seizure ( correspond clinical event ) 48hour video EEG screen A ketogenic diet Previous exposure levetiracetam Seizures close together count accurately Treatable seizure etiology Current diagnosis LennoxGastaut Syndrome epilepsy secondary progress cerebral disease Diagnosis terminal illness</criteria>
	<gender>All</gender>
	<minimum_age>1 Month</minimum_age>
	<maximum_age>4 Years</maximum_age>
	<verification_date>July 2015</verification_date>
	<keyword>Partial Onset Seizure</keyword>
	<keyword>levetiracetam</keyword>
	<keyword>Video Electroencephalogram</keyword>
	<keyword>Keppra</keyword>
</DOC>